Newsletter | August 17, 2026

08.17.26 -- Scaling Human-Relevant Science For Biologics Development

Building A Human-Centric Future For Biologics Development

Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.

 

Evaluating CAR T-Cell Therapy Vascular Recruitment, Trafficking, And Killing

Read about a human-centric platform that enables researchers to evaluate CAR T-cell functionality, including trafficking, killing efficiency, and administration of co-therapies.

 

Improving Gene Therapy Development With Organ-On-A-Chip Technology

Gene therapies hold tremendous promise. Explore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.

 

How Organ-Chips Are Transforming Women's Reproductive Health Research

Traditional models often fall short in women’s health research. Learn how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.

 

Ushering In A New Era Of Human-Relevant Drug Discovery

With most drug candidates failing before approval, researchers need better ways to predict human responses. In this interview with Emulate CEO Jim Corbett, delve into how advances in human-relevant modeling are helping improve decisions.

 

PRODUCT BROCHURE

Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery

As regulatory momentum continues growing to reduce and replace animal models with more human-relevant approaches, Emulate’s Organ-on-a-Chip technology can help researchers generate translational insights earlier in the R&D process and expedite their IND submissions. Discover emerging applications, scientific advances, and scalable workflows designed to help pharmaceutical teams integrate Organ-Chips into drug development with greater consistency, efficiency, and translational confidence. Download brochure.